Orthocell Ltd (AU:OCC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Orthocell Ltd (ASX: OCC) has requested a trading halt on its securities pending an important announcement regarding the regulatory study results necessary for FDA market approval of its product, Remplir, in the US. This strategic pause aims to manage market expectations and ensure investors are well-informed. The halt will remain effective until the announcement is made or until normal trading resumes on December 3, 2024.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.